Matches in Wikidata for { <http://www.wikidata.org/entity/Q64187985> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q64187985 description "clinical trial" @default.
- Q64187985 description "ensayu clínicu" @default.
- Q64187985 description "klinisch onderzoek" @default.
- Q64187985 description "клінічне випробування" @default.
- Q64187985 description "կլինիկական փորձարկում" @default.
- Q64187985 name "An Effectiveness and Safety Study of Ixazomib in Combination With Lenalidomide and Dexamethasone (IRD) in Participants With Multiple Myeloma (MM) Previously Receiving a Bortezomib-based Induction Regimen (US MM-6)" @default.
- Q64187985 type Item @default.
- Q64187985 label "An Effectiveness and Safety Study of Ixazomib in Combination With Lenalidomide and Dexamethasone (IRD) in Participants With Multiple Myeloma (MM) Previously Receiving a Bortezomib-based Induction Regimen (US MM-6)" @default.
- Q64187985 prefLabel "An Effectiveness and Safety Study of Ixazomib in Combination With Lenalidomide and Dexamethasone (IRD) in Participants With Multiple Myeloma (MM) Previously Receiving a Bortezomib-based Induction Regimen (US MM-6)" @default.
- Q64187985 P1050 Q64187985-D00A8F21-10E9-42E0-95F4-6F0017B6BBD6 @default.
- Q64187985 P1132 Q64187985-4FAA7B39-35E7-4453-9FD0-7A35DC88CDB0 @default.
- Q64187985 P1476 Q64187985-B56599EC-4CE5-441E-8DBA-47E5E1C7E690 @default.
- Q64187985 P17 Q64187985-8BFC61F7-CB31-44E7-9A93-52AC91033BE8 @default.
- Q64187985 P2899 Q64187985-286F5F7C-B93E-4B94-AA3D-74F500260BA3 @default.
- Q64187985 P3098 Q64187985-985FB8F2-56FC-46AE-8EAE-4AF9166D193D @default.
- Q64187985 P31 Q64187985-40D08343-01A6-4718-9BC9-9F0DBE02F732 @default.
- Q64187985 P4844 Q64187985-43FC2DAC-0043-4BB4-A6D6-DD08CF03834A @default.
- Q64187985 P4844 Q64187985-A2A8DFD4-8B61-471C-B535-E384C016A43A @default.
- Q64187985 P4844 Q64187985-DDFCFCB2-F86E-4BCB-B6C6-BE5EC5118446 @default.
- Q64187985 P580 Q64187985-17DD3767-E2D2-4FFB-A4C9-00ED73A2F63A @default.
- Q64187985 P582 Q64187985-75647915-DB4F-4ACA-A958-73DA71492B8D @default.
- Q64187985 P6099 Q64187985-DF51345A-AA51-4536-BA65-C93F92128335 @default.
- Q64187985 P6153 Q64187985-9DB5F24F-AFFE-4A00-8686-C49B924900B2 @default.
- Q64187985 P6153 Q64187985-EA1B1882-46F0-4878-9976-FB03851422F4 @default.
- Q64187985 P6153 Q64187985-EB62C6F3-9CA5-43D6-9FB2-2BBECDAECF8B @default.
- Q64187985 P6153 Q64187985-F392E4BB-5209-43F9-B630-54EF8C107BB9 @default.
- Q64187985 P8363 Q64187985-B388553E-53C1-41CC-8A2E-84F0E08BF4C1 @default.
- Q64187985 P1050 Q467635 @default.
- Q64187985 P1132 "+160" @default.
- Q64187985 P1476 "An Open-Label, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) in Patients With Multiple Myeloma Previously Receiving a Bortezomib-Based Induction Regimen (US MM-6)" @default.
- Q64187985 P17 Q30 @default.
- Q64187985 P2899 "+18" @default.
- Q64187985 P3098 "NCT03173092" @default.
- Q64187985 P31 Q30612 @default.
- Q64187985 P4844 Q20948663 @default.
- Q64187985 P4844 Q408524 @default.
- Q64187985 P4844 Q425681 @default.
- Q64187985 P580 "2017-09-20T00:00:00Z" @default.
- Q64187985 P582 "2023-11-30T00:00:00Z" @default.
- Q64187985 P6099 Q42825046 @default.
- Q64187985 P6153 Q30269592 @default.
- Q64187985 P6153 Q30286943 @default.
- Q64187985 P6153 Q5476635 @default.
- Q64187985 P6153 Q812573 @default.
- Q64187985 P8363 Q78089383 @default.